Clinical Trial Update: Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on an anti-PD-1 therapy for melanoma with brain metastases; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Melanoma

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Melanoma, Brain Metastases | Phase 2 | Status: ACTIVE_NOT_RECRUITING